BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/2/2024 8:41:37 AM | Browse: 72 | Download: 467
 |
Received |
|
2024-04-30 10:58 |
 |
Peer-Review Started |
|
2024-04-30 10:58 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-05-20 16:24 |
 |
Revised |
|
2024-05-29 09:10 |
 |
Second Decision |
|
2024-06-14 02:45 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-06-14 07:48 |
 |
Articles in Press |
|
2024-06-14 07:48 |
 |
Publication Fee Transferred |
|
2024-06-18 08:46 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-06-26 12:55 |
 |
Publish the Manuscript Online |
|
2024-07-02 08:41 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Obstetrics & Gynecology |
Manuscript Type |
Retrospective Study |
Article Title |
Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yang-Yang Kuang, Min-Qi Xiong and Jin-Xia Cai |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Yang-Yang Kuang, MM, Doctor, Doctor, Women's Health Management Center, Jiujiang Maternal and Child Health Hospital, No. 61 Gantang South Road, Xunyang District, Jiujiang 332000, Jiangxi Province, China. 13576207600@163.com |
Key Words |
γ-oryzanol; Femoston; Perimenopausal syndrome; Clinical effectiveness; Adverse reactions |
Core Tip |
Perimenopausal syndrome (PMS) is a chronic condition associated with estrogen deficiency. Hormone replacement therapy is the conventional treatment for PMS; however, because of possible adverse events such as stroke, breast cancer, endometrial cancer, glucose intolerance, and thromboembolic disease, its treatment alternatives must be continuously explored and optimized. Compared with Femoston monotherapy, proposed combination therapy of γ-oryzanol and Femoston has certain clinical advantages, including significantly better clinical efficacy, for treating patients with PMS. This treatment can prevent adverse reactions, actively regulate sex hormone levels, increase patient bone mineral density, and actively help improve sleep quality. |
Publish Date |
2024-07-02 08:41 |
Citation |
<p>Kuang YY, Xiong MQ, Cai JX. Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome. <i>World J Clin Cases</i> 2024; 12(22): 4992-4998</p> |
URL |
https://www.wjgnet.com/2307-8960/full/v12/i22/4992.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v12.i22.4992 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345